PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,784.00
Bid: 2,780.00
Ask: 2,782.00
Change: -14.00 (-0.50%)
Spread: 2.00 (0.072%)
Open: 2,788.00
High: 2,794.00
Low: 2,770.00
Prev. Close: 2,798.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATE

7 Jul 2023 07:00

RNS Number : 3262F
Coca-Cola HBC AG
07 July 2023
 

 

FOR IMMEDIATE RELEASE

 

TRADING UPDATE

 

COCA-COLA HBC UPGRADES PROFIT EXPECTATIONS AFTER STRONG PERFORMANCE IN FIRST SIX MONTHS OF THE YEAR

 

Zug, Switzerland - 7 July 2023 - Coca-Cola HBC AG ("Coca-Cola HBC") announces that, after a stronger than anticipated finish to the first six months of the year, it is upgrading its 2023 earnings expectations.

 

Performance in June, one of our most significant months, was very good overall. As a result, we now expect to deliver strong organic EBIT growth in the first half, led by operating leverage from double-digit top line growth, reflecting good improvements to price / mix.

 

As a result, we now expect organic EBIT growth for 2023 of 9-12% (previously the top end of a -3 to +3% range).

 

Our mid-term guidance from 2024 onwards is unchanged. We expect average annual organic revenue growth of 6-7% and average annual organic EBIT margin expansion of 20-40 basis points per annum.

 

The half-year 2023 results will be published on 9 August at 7:00 am BST.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the EU Market Abuse Regulation.

 

Enquiries

Coca‑Cola HBC Group

Investor and Analysts:

 

John Dawson 

Head of Investor Relations

Tel: +44 7522 619509

 john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

Virginia Phillips

Investor Relations Manager

 

Tel: +44 (0) 7864 686582

virginia.phillips@cchellenic.com

 

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Ciara Cashen

Senior Group Communications Manager

 +353 861940885

ciara.cashen@cchellenic.com

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate, and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa Coffee, Valser, Römerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRRMATMTIMMJJ
Date   Source Headline
22nd Jun 20211:19 pmRNSResult of AGM
18th Jun 20212:02 pmRNSDirector/PDMR Shareholding
10th Jun 202111:57 amRNSAthens Exchange trading date of ordinary shares
1st Jun 202111:01 amRNSIssue of equity and total voting rights
21st May 20217:00 amRNSNotice of AGM
18th May 20211:50 pmRNSDirector/PDMR Shareholding
12th May 20217:00 amRNSGood start in a challenging environment
4th May 202110:12 amRNSBlock listing Interim Review
4th May 202110:05 amRNSTotal voting rights
19th Apr 20214:34 pmRNSDirector/PDMR Shareholding
19th Apr 202112:05 pmRNSNotice of Results
1st Apr 20214:09 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:03 pmRNSElection of Home Member State
18th Mar 20215:12 pmRNSDirector/PDMR Shareholding
18th Mar 20212:26 pmRNS2020 integrated annual report 'Adapt to Win'
18th Mar 202112:52 pmRNSDirector/PDMR Shareholding
18th Mar 202112:27 pmRNSDirector/PDMR Shareholding
18th Mar 20219:50 amRNSDirector/PDMR Shareholding
1st Mar 20218:33 amRNSIssue of Equity
18th Feb 202112:14 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSOperational agility delivers resilient performance
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights
19th Nov 20203:44 pmRNSPublication of Suppl.Prospcts
18th Nov 20202:23 pmRNSDirector/PDMR Shareholding
11th Nov 20207:00 amRNSSTRONGLY IMPROVED TRADING IN Q3
2nd Nov 20209:07 amRNSIssue of equity and total voting rights
21st Oct 20205:00 pmRNSAppointment of Chief Financial Officer
19th Oct 20202:26 pmRNSDirector/PDMR Shareholding
12th Oct 202012:44 pmRNSNotice of Results
25th Sep 202010:09 amRNSDirector Declaration
18th Sep 20201:31 pmRNSDirector/PDMR Shareholding
9th Sep 20204:24 pmRNSPublication of Suppl.Prospcts
1st Sep 202010:31 amRNSIssue of equity and total voting rights
18th Aug 202012:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:08 pmRNSDirector Declaration
7th Aug 202010:54 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSENCOURAGING SIGNS AS MARKETS REOPEN
4th Aug 20203:05 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:01 amRNSTotal Voting Rights
31st Jul 20202:46 pmRNSNotice of Results-New time for the analysts call
20th Jul 20203:19 pmRNSDirector/PDMR Shareholding
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.